You searched for "Refraction"
Patient and public participation shapes biomedical research and access priorities in eye health
Patients, clinicians and clinician-scientists play a valuable role in shaping the future of vision research. Limited funding demands targeted research initiatives that ultimately will shape health policy and practice to secure progress in improving patient outcomes in eye health. This...Towards virtual reality conferences?
COVID-19 is forcing us to reconsider every aspect of life. The authors ask what future ophthalmic meetings could look like. The coronavirus disease COVID-19 pandemic disrupted ophthalmic conferences resulting in the cancellation of the majority of meetings in 2020, e.g....How to be a better optometrist – a personal view
Our optometry editor shares her personal observations of what makes the best optometrist. Some years ago in Glasgow, I gave a presentation with this same title, ‘How to be a better optometrist’. I was the optometry programme director for NHS...
SD-OCT detection of minimally visible retinoblastoma
This paper reports minimally visible tumour recurrence that was detectable on spectral domain OCT (SD-OCT) in a two-month old infant who had a diagnosis of bilateral familial retinoblastoma. The infant was treated with IVC for six cycles with vincristine, etoposide...
CSD-OCT detection of minimally visible retinoblastoma
This paper reports minimally visible tumour recurrence that was detectable on spectral domain OCT (SD-OCT) in a two-month-old infant who had a diagnosis of bilateral familial retinoblastoma. The infant was treated with IVC for six cycles with vincristine, etoposide and...Building data infrastructure for eye research in the NHS: Real-world lessons from the Liverpool Eye Data Platform
The Liverpool Eye Data Platform demonstrates how governance-compliant infrastructure can bring together routinely-collected, siloed NHS eye data. Routine care delivered across the NHS generates vast amounts of clinical data within a healthcare system that is uniquely characterised by comprehensive population...
Fenofibrate and diabetic retinopathy
Fenofibrate is an agonist of peroxisome proliferator-activated receptor-alpha (PPARα) which is used as a lipid-lowering agent. By reducing blood lipid levels, it can decrease retinal hard exudates which is beneficial in diabetic retinopathy (DR). FIELD and ACCORD studies show that...Optos announces new ultra-widefield colour image modality, providing additional retinal visualisation to eyecare professionals
Optos, Plc, the leading retinal imaging company, announces it is expanding the optomap® ultra-widefield (UWF™) retinal imaging modalities available with the California FA device to further assist eyecare professionals in disease management and treatment planning.Children’s competition helping kids get the right glasses to combat preventable childhood blindness
Ahead of World Sight Day 2024 on the 10th October, the International Agency for the Prevention of Blindness (IAPB) is putting children’s eye health at the centre of their Love Your Eyes campaign, with the Glasses of the Future competition....Biotech Healthcare transforms lives through its CSR initiative, 'I See You'
Biotech Healthcare, one of the fastest growing companies in the ophthalmic industry, continues to make a meaningful impact with its transformative Corporate Social Responsibility (CSR) initiative, 'I See You.' This program reflects the company’s mission of ‘Access to Innovation’ by...
Fellow eye comparison of DMEK and PKP
This retrospective analysis of 11 patients who underwent penetrating keratoplasty (PKP) in their first eye followed by descemet membrane endothelial keratoplasty (DMEK) in their second eye studied visual and refractive outcomes. Intra and postoperative complications were compared and a subjective...
